206 related articles for article (PubMed ID: 31068300)
41. Influence of MiR-451 on Drug Resistances of Paclitaxel-Resistant Breast Cancer Cell Line.
Gu X; Li JY; Guo J; Li PS; Zhang WH
Med Sci Monit; 2015 Oct; 21():3291-7. PubMed ID: 26516138
[TBL] [Abstract][Full Text] [Related]
42. Enhanced chemosensitization in multidrug-resistant human breast cancer cells by inhibition of IL-6 and IL-8 production.
Shi Z; Yang WM; Chen LP; Yang DH; Zhou Q; Zhu J; Chen JJ; Huang RC; Chen ZS; Huang RP
Breast Cancer Res Treat; 2012 Oct; 135(3):737-47. PubMed ID: 22923236
[TBL] [Abstract][Full Text] [Related]
43. [The effect of Bcl-2 gene silencing on the sensitivity of cell line A549 to chemotherapeutic drugs].
Wang JQ; Du ZW; Gao XF; Wu M; Zhang YC; Pan Y; Wang Q; Zhang GZ
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):191-7. PubMed ID: 23856142
[TBL] [Abstract][Full Text] [Related]
44. Effect of NIMA-related kinase 2B on the sensitivity of breast cancer to paclitaxel in vitro and vivo.
Wang Y; Shen H; Yin Q; Zhang T; Liu Z; Zhang W; Niu Y
Tumour Biol; 2017 May; 39(5):1010428317699754. PubMed ID: 28475000
[TBL] [Abstract][Full Text] [Related]
45. Adenovirus-mediated p53 gene therapy reverses resistance of breast cancer cells to adriamycin.
Qi X; Chang Z; Song J; Gao G; Shen Z
Anticancer Drugs; 2011 Jul; 22(6):556-62. PubMed ID: 21637162
[TBL] [Abstract][Full Text] [Related]
46. Small interfering RNA (siRNA)-mediated silencing of the M2 subunit of ribonucleotide reductase: a novel therapeutic strategy in ovarian cancer.
Zhang M; Wang J; Yao R; Wang L
Int J Gynecol Cancer; 2013 May; 23(4):659-66. PubMed ID: 23466567
[TBL] [Abstract][Full Text] [Related]
47. MST2 silencing induces apoptosis and inhibits tumor growth for estrogen receptor alpha-positive MCF-7 breast cancer.
Park J; Kim GH; Lee J; Phuong BTC; Kong B; Won JE; Won GW; Lee YH; Han HD; Lee Y
Toxicol Appl Pharmacol; 2020 Dec; 408():115257. PubMed ID: 33007383
[TBL] [Abstract][Full Text] [Related]
48. Short-hairpin RNA-mediated Heat shock protein 90 gene silencing inhibits human breast cancer cell growth in vitro and in vivo.
Zuo K; Li D; Pulli B; Yu F; Cai H; Yuan X; Zhang X; Lv Z
Biochem Biophys Res Commun; 2012 May; 421(2):396-402. PubMed ID: 22521890
[TBL] [Abstract][Full Text] [Related]
49. [Preliminary study of the prohibitin protein and paclitaxel resistance in ovarian cancer].
Tang J; Cao L; Yi H; Tang C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Dec; 37(12):1221-7. PubMed ID: 23281375
[TBL] [Abstract][Full Text] [Related]
50. [Effect of siRNA transfection targeting VEGF gene on proliferation and apoptosis of human breast cancer cells].
Zhang X; Xu WH; Ge YL; Hou L; Li Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jan; 23(1):14-7. PubMed ID: 17210097
[TBL] [Abstract][Full Text] [Related]
51. ShRNA targeting Notch1 sensitizes breast cancer stem cell to paclitaxel.
Mao J; Song B; Shi Y; Wang B; Fan S; Yu X; Tang J; Li L
Int J Biochem Cell Biol; 2013 Jun; 45(6):1064-73. PubMed ID: 23500524
[TBL] [Abstract][Full Text] [Related]
52. [Effect of peroxiredoxin I gene silencing on the radiosensitivity of breast carcinoma MCF-7 cell xenograft in nude mice].
Guo QS; Huang X; Li SL
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(7):1119-23. PubMed ID: 21764677
[TBL] [Abstract][Full Text] [Related]
53. Salvianolic acid A reverses paclitaxel resistance in human breast cancer MCF-7 cells via targeting the expression of transgelin 2 and attenuating PI3 K/Akt pathway.
Cai J; Chen S; Zhang W; Zheng X; Hu S; Pang C; Lu J; Xing J; Dong Y
Phytomedicine; 2014 Oct; 21(12):1725-32. PubMed ID: 25442283
[TBL] [Abstract][Full Text] [Related]
54. Knockdown of the c-Jun-N-terminal kinase expression by siRNA inhibits MCF-7 breast carcinoma cell line growth.
Parra E; Ferreira J
Oncol Rep; 2010 Nov; 24(5):1339-45. PubMed ID: 20878129
[TBL] [Abstract][Full Text] [Related]
55. Short hairpin RNA-mediated gene silencing of ADAM17 inhibits the growth of breast cancer MCF‑7 cells in vitro and in vivo and its mechanism of action.
Hu B; Meng X; Zhang Y; Hossain MM; Wu L; Zhang Y; Peng X; Zhang X
Oncol Rep; 2018 Apr; 39(4):1640-1648. PubMed ID: 29393483
[TBL] [Abstract][Full Text] [Related]
56. Silencing of Bmi-1 gene by RNA interference enhances sensitivity to doxorubicin in breast cancer cells.
Wu X; Liu X; Sengupta J; Bu Y; Yi F; Wang C; Shi Y; Zhu Y; Jiao Q; Song F
Indian J Exp Biol; 2011 Feb; 49(2):105-12. PubMed ID: 21428211
[TBL] [Abstract][Full Text] [Related]
57. Effective Gene Silencing Mediated by Polypeptide Nanoparticles LAH4-L1-siMDR1 in Multi-Drug Resistant Human Breast Cancer.
Liu J; Guo N; Gao C; Liu N; Zheng X; Tan Y; Lei J; Hao Y; Chen L; Zhang X
J Biomed Nanotechnol; 2019 Mar; 15(3):531-543. PubMed ID: 31165698
[TBL] [Abstract][Full Text] [Related]
58. Silencing MAP3K1 expression through RNA interference enhances paclitaxel-induced cell cycle arrest in human breast cancer cells.
Hu P; Huang Q; Li Z; Wu X; Ouyang Q; Chen J; Cao Y
Mol Biol Rep; 2014 Jan; 41(1):19-24. PubMed ID: 24253898
[TBL] [Abstract][Full Text] [Related]
59. [Molecular mechanisms of resistance to phosphatidyl inositol 3-kinase inhibitors in triple-negative breast cancer cells].
Zhang WL; Ma WJ; Chen S; Wu XZ; Zhang HR; Zhang JH
Zhonghua Zhong Liu Za Zhi; 2016 Aug; 38(8):578-88. PubMed ID: 27531477
[TBL] [Abstract][Full Text] [Related]
60. [Effect of silencing hypoxia-inducible factor-1 alpha by RNA interference on human breast carcinoma cell line].
Wang H; Liu YJ; Han ZB; Liang LH; Lv LL; Han ZC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Oct; 28(5):670-4. PubMed ID: 17121229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
